Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Femke de Snoo

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Virchows Archiv : an International Journal of Pathology|July 6, 2016
An international study comparing conventional versus mRNA level testing (TargetPrint) for ER, PR, and HER2 status of breast cancerJelle Wesseling, Corrado Tinterri, Anna Sapino, et al.
International Journal of Molecular Medicine|November 3, 2010
Comparison of MammaPrint and TargetPrint results with clinical parameters in German patients with early stage breast cancerHeidrun Gevensleben, Uwe-Jochen Göhring, Reinhard Büttner, et al.
Ejhaem|July 18, 2022
Gene expression profiling impacts treatment decision making in newly diagnosed multiple myeloma patients in the prospective PROMMIS trialNoa Biran, Binod Dhakal, Suzanne Lentzsch, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Virchows Archiv : an International Journal of Pathology|July 6, 2016
An international study comparing conventional versus mRNA level testing (TargetPrint) for ER, PR, and HER2 status of breast cancerJelle Wesseling, Corrado Tinterri, Anna Sapino, et al.
International Journal of Molecular Medicine|November 3, 2010
Comparison of MammaPrint and TargetPrint results with clinical parameters in German patients with early stage breast cancerHeidrun Gevensleben, Uwe-Jochen Göhring, Reinhard Büttner, et al.
Ejhaem|July 18, 2022
Gene expression profiling impacts treatment decision making in newly diagnosed multiple myeloma patients in the prospective PROMMIS trialNoa Biran, Binod Dhakal, Suzanne Lentzsch, et al.
Pageof 2